Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hydrogels could lead to better treatments for wound healing without scars.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

The most common causes of hair loss in Jordanian children are fungal infections, autoimmune hair loss, and hair shedding after fever, with zinc deficiency also being a notable cause.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Minoxidil lowers blood pressure and causes hair growth, with some side effects.

Boxer and Labrador dogs' hair growth is affected by the tropical climate, but Schnauzers' is not.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Six African American women experienced hair loss after switching to a new HIV medication.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Steroids, infection management, and nutritional support can significantly improve symptoms of Cronkhite-Canada Syndrome.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

A man's baldness improved possibly due to a medication that blocks male hormones.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.